Open kdm9 opened 7 years ago
One consideration to add to this, if LGPL is on the table, is the possibility of full GPL - the major advantage being that practically all existing Bio-software is GPL, and having GPL would make simply porting any elements of that software legal and license-compliant. This opens a huge library of potential code to copy/port.
Hi all,
@Ward9250 and I had a chat about license choices on gitter. As we move to independent packages, maintainers may want to vary licenses from the default, very liberal MIT license. There are many alternatives, but the three that have been mentioned are:
To quote Ben, this is motivated by the idea that
I wholeheartedly agree with this sentiment, and would like to license Kmers.jl under the MPL2. What do other contributors feel?
If someone outside academia is reading this, I'd love your opinion on whether or not this change would affect you in any way (either increase the chances of contribution, or decrease the chances of you using BioJulia software). We have no intention of making this software harder for anyone to use, including commercially.
(By the way, this issue is meant to start a conversation. Nothing has been decided.)
Cheers, K